Copyright
©The Author(s) 2017.
World J Gastroenterol. May 28, 2017; 23(20): 3721-3729
Published online May 28, 2017. doi: 10.3748/wjg.v23.i20.3721
Published online May 28, 2017. doi: 10.3748/wjg.v23.i20.3721
Table 2 Proliferating cell nuclear antigen and E-cadherin expression in the two groups
| Group | No. of cases | PCNA | E-cadherin | ||||||
| - | + | ++ | +++ | - | + | ++ | +++ | ||
| Normal group | 40 | 29 | 6 | 4 | 1 | 5 | 15 | 11 | 9 |
| Gastric cancer group | 66 | 16 | 11 | 17 | 22 | 45 | 11 | 7 | 3 |
| Z-value | - | -5.231 | -4.982 | ||||||
| P-value | - | 0.000 | 0.000 | ||||||
- Citation: Hu L, Li HL, Li WF, Chen JM, Yang JT, Gu JJ, Xin L. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma. World J Gastroenterol 2017; 23(20): 3721-3729
- URL: https://www.wjgnet.com/1007-9327/full/v23/i20/3721.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i20.3721